Drug Shortage Report for ARTHROTEC 75
Report ID | 245769 |
Drug Identification Number | 02229837 |
Brand name | ARTHROTEC 75 |
Common or Proper name | ARTHROTEC 75 |
Company Name | PFIZER CANADA ULC |
Market Status | MARKETED |
Active Ingredient(s) | MISOPROSTOL DICLOFENAC SODIUM |
Strength(s) | 200MCG 75MG |
Dosage form(s) | TABLET (DELAYED-RELEASE) |
Route of administration | ORAL ORAL |
Packaging size | 1x250 |
ATC code | M01AB |
ATC description | ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2025-02-12 |
Actual start date | |
Estimated end date | 2025-04-30 |
Actual end date | |
Shortage status | Anticipated shortage |
Updated date | 2025-02-03 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2025-02-03 | French | Compare |
v7 | 2025-02-03 | English | Compare |
v6 | 2025-01-24 | French | Compare |
v5 | 2025-01-24 | English | Compare |
v4 | 2025-01-08 | French | Compare |
v3 | 2025-01-08 | English | Compare |
v2 | 2024-12-16 | French | Compare |
v1 | 2024-12-16 | English | Compare |
Showing 1 to 8 of 8